Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 13.60
+0.05 (0.37%)
Feb 11, 2026, 1:49 PM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 7.92 billion as of February 11, 2026. Its market cap has decreased by -23.11% in one year.
Market Cap
7.92B
Enterprise Value
3.08B
Revenue
301.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
13.60
Market Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 7.92B, a decrease of -65.46%. That is a compound annual growth rate of -34.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 7.92B | -11.39% |
| Dec 31, 2025 | 8.94B | -10.43% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TCM Biotech International | 10.78B |
| PharmaEngine | 9.14B |
| TaiGen Biopharmaceuticals Holdings | 8.76B |
| Gongwin Biopharm Holdings | 8.63B |
| Adimmune | 7.67B |
| Mycenax Biotech | 6.91B |
| OBI Pharma | 6.19B |
| Savior Lifetec | 6.07B |